Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.
Alimentary pharmacology & therapeutics（2023）
摘要
LINKED CONTENT This article is linked to Volkers et al paper. To view this article, visit
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要